#CSL has said that with #flujabrates in the #US down between 12% and 14% this year, it has decided to delay the planned spinout of its #Seqirus vaccines business and cut its #profitforecast for the financial year.
pharmaphorum.com/news/falling...
#today I deviated from my daily walk to pop into the local pharmacy/chemist and get myself a 'flu jab (£25 — I am not old or frail enough to get it free this year): "Cell-based trivalent Influenza Vaccine (Surface Antigen, Inactivated) Seqirus 2025/2026 Season, Lot 3051272, EXP: 05/2026". Some […]
Pharmaceutical companies MUST move beyond RFK’s obstruction delays, and move ahead together to formulate next years flu vaccine. Work with #AMA. NOW !!!!! #EliLily,
#SanofiPasteur, #CSL #Seqirus, #GlaxoSmithKline, #AstraZeneca, and #MedImmune. Do NOT wait for stupid #RFKjr to act!!!!!
